Grade 3/4 nonhematologic AEs (occurring in >1 patient per chemotherapy cohort)
| Patients . | G-CHOP . | G-FC . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 400/400 mg (n = 14) . | 1600/800 mg (n = 14) . | Total (n = 28) . | 400/400 mg (n = 14) . | 1600/800 mg (n = 14) . | Total (n = 28) . | |||||||
| No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
| Infections | 3 | 21 | 3 | 21 | 6 | 21 | 1 | 7 | 4 | 29 | 5 | 18 |
| IRR | 1 | 7 | 1 | 7 | 2 | 7 | 1 | 7 | 1 | 7 | 2 | 7 |
| Vomiting | 1 | 7 | 1 | 7 | 2 | 7 | — | — | — | |||
| Patients . | G-CHOP . | G-FC . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 400/400 mg (n = 14) . | 1600/800 mg (n = 14) . | Total (n = 28) . | 400/400 mg (n = 14) . | 1600/800 mg (n = 14) . | Total (n = 28) . | |||||||
| No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | No. . | % . | |
| Infections | 3 | 21 | 3 | 21 | 6 | 21 | 1 | 7 | 4 | 29 | 5 | 18 |
| IRR | 1 | 7 | 1 | 7 | 2 | 7 | 1 | 7 | 1 | 7 | 2 | 7 |
| Vomiting | 1 | 7 | 1 | 7 | 2 | 7 | — | — | — | |||